spastic paraplegia-severe developmental delay-epilepsy syndrome

ORPHA: 464282

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with spastic paraplegia-severe developmental delay-epilepsy syndrome, sourced from HPO and Orphanet clinical annotations.

SeizureGlobal developmental delayProgressive spastic paraplegiaHypertelorismSensorineural hearing impairmentDeeply set eyeMyopiaRetinal dystrophyDelayed speech and language developmentIntellectual disabilityAtaxiaSpasticityDysarthriaGait disturbanceDystoniaLower limb spasticityGeneralized myoclonic seizureUnsteady gaitWaddling gaitScoliosisDownturned corners of mouthKyphosisHip dislocationAxial hypotoniaExophoriaAbsent pubertal growth spurtUrinary incontinenceMicrocephalyObesityCerebral atrophyBilateral tonic-clonic seizureHypoplasia of the corpus callosumShort staturePuberty and gonadal disordersStructural foot deformityFocal myoclonic seizureDelayed peripheral myelinationCerebral white matter atrophy

Classification & Codes

Orphanet Code

ORPHA:464282
spastic paraplegia-severe developmental delay-epilepsy syndrome
OrphanetORPHA:464282
Treatments0 drug(s)
Symptoms on record38 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO